# Microorganism in Overactive Bladder Patients

> **NCT00883818** · PHASE4 · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 84 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** azithromycin, doxycycline

## Key facts

- **NCT ID:** NCT00883818
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2009-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00883818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00883818, "Microorganism in Overactive Bladder Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00883818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*